RESILIENCE
DEAD

Serial Number

86319766

Owner

Resilience Pharmaceuticals, Inc.

Filing Date

Jun 25, 2014

Add to watchlist:

No watchlists yet
View on USPTO

RESILIENCE Trademark

Serial Number: 86319766

RESILIENCE is a trademark filed by Resilience Pharmaceuticals, Inc. on June 25, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Resilience Pharmaceuticals, Inc.

72 Bay State Avenue
Somerville, MA 02144

Entity Type: 03

Trademark Details

Filing Date

June 25, 2014

Registration Date

Not Registered

Goods & Services

Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for post-traumatic stress disorder.; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of post-traumatic stress disorder.; Pharmaceutical preparations for the treatment and prevention of post-traumatic stress disorder.; Pharmaceutical preparations for post-traumatic stress disorder.; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of post-traumatic stress disorder.; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Therapeutic pharmaceutical for the treatment of post-traumatic stress disorder

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of post-traumatic stress disorder.; Research on the subject of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

UNDELIVERABLE MAIL - NO ACTION TAKEN
Jun 5, 2015 UNDN
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 8, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 8, 2015 ABN2
NON-FINAL ACTION MAILED
Oct 7, 2014 CNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2014 CNRT
ASSIGNED TO EXAMINER
Oct 2, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2014 NWOS
NEW APPLICATION ENTERED
Jun 28, 2014 NWAP